- July 13, 2017
- Posted by:
- Category: FundingSMEs.com
NewLeaf Symbiotics has raised $24 million in Series C funding.
Founded in 2012, NewLeaf Symbiotics develops and commercializes the bacteria found in Pink Pigmented Facultative Methylotrophs.
NewLeaf will use the invested capital to commercialize seed treatment and in-furrow products for soybeans, corn, wheat, peanuts, and other crops. The company is tripling the size of its R&D and pilot production facility in St. Louis and is expanding its proprietary Prescriptive Biologics Knowledgebase™ bioinformatics platform.
|City||St Louis, Missouri|
|Founder / CEO||Thomas Laurita|
|Investors||Monsanto Growth Ventures (MGV)|
|Lewis & Clark Ventures|
|Previous Investors||Palo Alto Investors|